Development and validation of a QbD-based RP-HPLC method for vericiguat quantification

Authors

  • Shubham Mandhare Department of Pharmaceutical Quality Assurance, Pravara Rural College of Pharmacy Pravaranagar, Tal-Rahata, District-Ahmednagar, Maharashtr
  • Rahul Godge Department of Pharmaceutical Quality Assurance, Pravara Rural College of Pharmacy Pravaranagar, Tal-Rahata, District-Ahmednagar, Maharashtr
  • Akshay Vikhe Department of Pharmaceutical Quality Assurance, Pravara Rural College of Pharmacy Pravaranagar, Tal-Rahata, District-Ahmednagar, Maharashtr
  • Shubham Talole Department of Pharmaceutical Quality Assurance, Pravara Rural College of Pharmacy Pravaranagar, Tal-Rahata, District-Ahmednagar, Maharashtr

DOI:

https://doi.org/10.18231/j.joapr.2024.12.2.57.67

Keywords:

Quality by Design (QbD), RP High Performance Liquid Chromatography (RP-HPLC), Vericiguat, Central Composite Design (CCD)

Abstract

Aim: An RP-HPLC method for Vericiguat using the QbD approach was developed and validated by ICH guidelines. Method: The ICH (Q2R1) guidelines have been followed in the development and validation of an RP-HPLC technique by considering several validation parameters like linearity, precision, LOD, LOQ, and accuracy. The study was performed on Agilent Tech using the C18 column (4.6x250 mm; 5 µm) and Chemstation 10.1 software with statistical data analysis, and the detector used was UV (DAD). Results: The mobile phase used for separation was Methanol: 0.1% OPA in the ratio of (76:24) at room temperature, the flow rate was 0.8ml/min, and the wavelength was 331nm. The results indicated that the quantification limit was 0.7209 µg/ml, and the detection limit was 0.2379 µg/ml. Conclusion: The validation studies confirmed that the developed method is fast, accurate, precise, cost-effective, selective, and useful for routine analysis of vericiguat in tablet dosage forms.

Downloads

Download data is not yet available.

References

Alhakeem M, Ghica M, Pîrvu C. Analytical quality by design with the lifecycle approach: A modern epitome for analytical method development. Acta Marisiensis – Seria, 65(2), 37 – 44 (2019)

Dewi MK, Pratama R, Arifka M, Chaerunisaa A. Quality by Design: Approach to Analytical Method Validation. Sciences of Pharmacy, 1(1), 33-40 (2022).

Foram P, Yadav P. Stability Indicating HPLC Method Development and Validation of Vericiguat in tablet dosage form. World Journal of Pharmacy and Pharmaceutical Sciences, 12(7), 420-429 (2023).

Joshi NA, Amrutkar SV, Upasani CD. Analytical Quality-by-Design Approach to Stability Indicating RP-HPLC Method Development and Validation for Estimation of Favipiravir in Bulk and Formulation. European Chemical Bulletin, 12(9), 118-133(2023).

Kang C, Lamb Y. Vericiguat: A review in chronic heart failure with reduced ejection fraction. American Journal of Cardiovascular Drugs, 22(4), 451-459 (2022).

Kumar L. Quality-by-design driven analytical method (AQbD) development and validation of HPLC-UV technique to quantify rivastigmine hydrogen tartrate in lipidic nanocarriers: Forced degradation, and assessment of drug content and in vitro release studies. Microchemical Journal, 193, 108944 (2023).

Mahapatra A, Meyyanathan S. Approach of analytical quality by design and regulatory need. International Journal of Health Sciences, 6(S5), 2572–2592 (2022).

Pravalika P, Jephthah G. A new RP-HPLC method for estimation of vericiguat in bulk drug and pharmaceutical dosage form. Journal of Advanced Scientific Research, 14(09), 37-43 (2023).

Mandpe SR, Parate VR. Method optimization and analysis of flurbiprofen loaded Eudragit L100 nanoparticles using RP-HPLC technique: A central composite design approach. Materials Today: Proceedings, 45(6), 4777-4786 (2021).

Mandpe SR, Parate VR. Experimental design approach, screening and optimization of system variables, analytical method development of flurbiprofen in nanoparticles and stability- indicating methods for HPLC. Futur J Pharm Sci., 8, 38 (2022).

Nagar P, Garg M, Chauhan C. Analytical Quality by Design (AQBD) Approach for HPLC method development, method optimization and validation. Quality Assurance, 13(2), 103-110 (2022).

Ramalingam P. QbD considerations for analytical development. In Pharmaceutical Quality by Design, 77-108 (2019).

Sawarkar KT, Asnani AJ. Quality by Design (QbD): Building and Enhancing Quality of Pharmaceuticals. International Journal of Pharmaceutical Research and Applications, 7(3), 1738-1748 (2022).

Urmi KF, Nawaz M, Islam SM. Analytical quality by design approach to RP-HPLC method development and validation for simultaneous estimation of esomeprazole and naproxen in modified-release dosage form. Future Journal of Pharmaceutical Sciences, 8(1), 1-16 (2022).

Volta e Sousa L, Gonçalves R. Analytical method lifecycle management in pharmaceutical industry: A review. AAPS Pharmscitech, 22, 1-14 (2021).

Varnekar DS, Sanjay NT. Quality by Design Approach-To Analytical Method Validation. International Journal for Multidisciplinary Research, 5(2), 1-8 (2023).

Published

2024-04-30

How to Cite

Mandhare, S., Godge, R. ., Vikhe, A., & Talole, S. (2024). Development and validation of a QbD-based RP-HPLC method for vericiguat quantification. Journal of Applied Pharmaceutical Research, 12(2), 57-67. https://doi.org/10.18231/j.joapr.2024.12.2.57.67

Issue

Section

Articles